Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...
An event addressing the alarming prevalence, persistent dangers and continuing tragedies of opioid misuse, addiction and fentanyl overdose has been scheduled for the evening of Wednesday, Feb. 12. The ...